SCHEMBL25901936

SCHEMBL25901936

CC(C)(C)OC(=O)N1CC[C@@H](O)[C@](C)(F)C1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.47
HPGD P15428 1/20 0.46
RECQL P46063 1/20 0.43
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR119 Q8TDV5 4/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPN6 P29350 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
EPHX2 P34913 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31080158 1.00 EPHX1 (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL15740632 1.00 EPHX1 (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL31080572 1.00 EPHX1 (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL25901853 1.00 EPHX1 (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL17630844 0.86 HPGD (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL17630680 0.86 HPGD (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL1965038 0.86 HPGD (0.47) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL14671956 0.84 HPGD (0.48) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL14671811 0.84 HPGD (0.48) EPHX1HPGDRECQLUSP2SMN1; SMN2
SCHEMBL2777507 0.84 HPGD (0.48) EPHX1HPGDRECQLUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695238-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2026-02-18 EP disclosed
WO-2024216154-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-10-17 WO disclosed
WO-2023134266-A1 2-PIPERIDYL OR 2-PYRAZOLYL SUBSTITUTED PYRIMIDINE COMPOUND SERVING AS EGFR INHIBITOR 苏州浦合医药科技有限公司 2023-07-20 WO disclosed